The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review
Lung cancer is the leading cause of cancer-related morbidity and mortality. The median survival time for patients with advanced non-small-cell lung cancer before the era of molecular-based personalized treatment was 7.9 months. The discovery of predictive factors and the introduction of molecular di...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2024-10-01
|
| Schriftenreihe: | Biomedicines |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2227-9059/12/10/2308 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|